EARNEST PARTNERS LLC / NABI BIOPHARMACEUTICALS
|
|
|
SEC 1745 (02-02)
|
|
Potential persons who are to respond
to the collection of information
contained in this form are not
required to respond unless the form
displays a currently valid OMB
control number. |
|
|
|
|
|
OMB APPROVAL |
|
|
OMB Number: 3235-0145 |
|
|
Expires: December 31, 2005 |
|
|
Estimated average burden
hours per response. . . 11 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Nabi Biopharmaceuticals
Common Stock
(Title of Class of Securities)
629519109
11/30/2005
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x Rule 13d-1(b)
o Rule 13d-1(c)
o Rule 13d-1(d)
|
|
|
|
|
|
|
CUSIP No. 629519109 |
|
|
1. |
Name of Reporting Person: EARNEST Partners, LLC |
I.R.S. Identification Nos. of above persons (entities only):
|
|
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions): |
|
|
(a) |
o |
|
|
|
(b) |
o |
|
|
|
3. |
SEC Use Only: |
|
|
4. |
Citizenship or Place of Organization: State of Georgia |
|
Number of Shares Beneficially Owned by Each Reporting Person With |
5. |
Sole Voting Power: 1,213,012 |
|
6. | Shared Voting Power: 406,143 |
|
7. | Sole Dispositive Power: 2,626,591 |
|
8. | Shared Dispositive Power: 0 |
|
|
9. | Aggregate Amount Beneficially Owned by Each Reporting Person: 2,626,591 |
|
|
10. | Check if the
Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions): Not Applicable |
|
|
11. | Percent of Class Represented by Amount in Row (11): 4.4% |
|
|
12. | Type of Reporting Person (See Instructions): IA |
|
2
|
|
|
|
|
Item 1. |
|
|
|
|
|
|
(a)
|
|
Name of Issuer Nabi Biopharmaceuticals |
|
|
|
|
|
|
|
(b)
|
|
Address of Issuers Principal Executive Offices 5800 Park of Commerce Boulevard N.W., Boca Raton,
FL 02324 |
|
|
|
|
|
Item 2. |
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Name of Person Filing EARNEST Partners, LLC |
|
|
|
|
|
|
|
(b)
|
|
Address of Principal Business Office or, if none, Residence 75 Fourteenth Street, Suite 2300,
Atlanta, Georgia 30309 |
|
|
|
|
|
|
|
(c)
|
|
Citizenship State of Georgia |
|
|
|
|
|
|
|
(d)
|
|
Title of Class of Securities Common Stock |
|
|
|
|
|
|
|
(e)
|
|
CUSIP Number 629519109 |
|
|
|
|
|
|
|
Item 3. |
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
|
|
|
|
|
|
(a)
|
|
o
|
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
|
|
|
|
|
|
|
|
|
(b)
|
|
o
|
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
|
|
|
|
(c)
|
|
o
|
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.
78c). |
|
|
|
|
|
|
|
|
|
(d)
|
|
o
|
|
Investment company registered under section 8 of the Investment Company
Act of 1940 (15 U.S.C 80a-8). |
|
|
|
|
|
|
|
|
|
(e)
|
|
x
|
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
|
|
|
|
(f)
|
|
o
|
|
An employee benefit plan or endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
|
|
|
|
(g)
|
|
o
|
|
A parent holding company or control person in accordance with §
240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
|
|
|
|
(h)
|
|
o
|
|
A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
|
|
|
|
|
|
(i)
|
|
o
|
|
A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3); |
|
|
|
|
|
|
|
|
|
(j)
|
|
o
|
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
|
|
|
|
|
(a) |
|
Amount beneficially owned: 2,626,591 |
|
|
|
|
|
(b) |
|
Percent of class: 4.4% |
|
|
|
|
|
(c) |
|
Number of shares as to which the person has: |
|
|
|
|
|
|
|
(i)
|
|
Sole power to vote or to direct the vote 1,213,012 |
|
|
|
|
|
|
|
(ii)
|
|
Shared power to vote or to direct the vote 406,143 |
|
|
|
|
|
|
|
(iii)
|
|
Sole power to dispose or to direct the disposition of 2,626,591 |
|
|
|
|
|
|
|
(iv)
|
|
Shared power to dispose or to direct the disposition of 0 |
Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d3(d)(1).
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ X ].
Instruction: Dissolution of a group requires a response to this item.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the
class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or
the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. EARNEST Partners, LLC is filing as an investment adviser
in accordance with §240.13d-1(b)(1)(ii)(E). No EARNEST Partners, LLC clients interest relates to more than five percent of the class.
|
|
|
Item 7.
|
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
or Control Person. |
If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an
exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this
schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Not Applicable
Item 8. Identification and Classification of Members of the Group
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item
3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating
the identity of each member of the group. Not Applicable
Item 9. Notice of Dissolution of Group
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to
transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Not Applicable
Item 10. Certification
|
(a) |
|
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b): |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to
above were acquired and are held in the ordinary course of business and were not acquired and are
not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
|
(b) |
|
The following certification shall be included if the statement is filed pursuant to §240.13d-1(c): |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to
above were not acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
|
|
|
|
|
December 12, 2005 |
|
|
|
|
|
Date |
|
|
|
|
|
James M. Wilson |
|
|
|
|
|
Signature |
|
|
|
|
|
James M. Wilson, Chief Compliance Officer |
|
|
|
|
|
Name/Title |